1. Home
  2. SCYX vs DAIO Comparison

SCYX vs DAIO Comparison

Compare SCYX & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$0.66

Market Cap

24.6M

Sector

Health Care

ML Signal

HOLD

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$2.86

Market Cap

23.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCYX
DAIO
Founded
1999
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.6M
23.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SCYX
DAIO
Price
$0.66
$2.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$5.22
AVG Volume (30 Days)
563.4K
24.7K
Earning Date
11-05-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,932,000.00
$22,701,000.00
Revenue This Year
$167.73
$9.14
Revenue Next Year
$290.78
$2.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$1.88
52 Week High
$1.49
$3.57

Technical Indicators

Market Signals
Indicator
SCYX
DAIO
Relative Strength Index (RSI) 45.86 56.99
Support Level $0.65 $2.65
Resistance Level $0.72 $2.89
Average True Range (ATR) 0.05 0.17
MACD 0.01 0.04
Stochastic Oscillator 54.91 100.00

Price Performance

Historical Comparison
SCYX
DAIO

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

Share on Social Networks: